Optimal Bronchodilation for COPD Patients: Are All Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonists the Same?

Optimal Bronchodilation for COPD Patients: Are All Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonists the Same?

Bronchodilators provide improvements in lung function and reductions in symptoms and exacerbations, and are the mainstay of pharmacological management of chronic obstructive pulmonary disease (COPD). The Global Initiative for Chronic Obstructive Lung Disease strategy recommends the use of a combinat...

Full description

Bibliographic Details
Main Authors: Marc Miravitlles, M.D., Seungjae Baek, M.D., Vatsal Vithlani, M.Pharm., Rahul Lad, Ph.D.
Format: Article
Language:English
Published: The Korean Academy of Tuberculosis and Respiratory Diseases 2018-07-01
Series:Tuberculosis and Respiratory Diseases
Subjects:
asian
pulmonary disease
chronic obstructive
disease management
korea
Online Access:https://e-trd.org/search.php?where=aview&id=10.4046/trd.2018.0040&code=0003TRD&vmode=FULL

Internet

https://e-trd.org/search.php?where=aview&id=10.4046/trd.2018.0040&code=0003TRD&vmode=FULL

Similar Items